Attached is a PowerPoint file with detail Information - IABMR

mutebabiesBiotechnology

Dec 6, 2012 (4 years and 11 months ago)

185 views

Global Venture Forum

-
the most effective way to find business partners in Japan
-

BIO Industry in Japan

+Market Size+


12.5 billion USD



2001


㈴〮㌠扩b汩l渠啓U


2010


2001

2005

2010

2025

Japan 12.5 billion US$

Europe

19.2 trillion US$

USA 28.8 trillion US$

Europe 115.3 billion US$

Japan 240.3 billion US$

Worldwide

2211.5 billion US$

USA 2884.6 billion US$

2003

Japan 16.3 billion US$

Source: Overview of Biotechnology Strategy Council

Hokkaido


the number of bio
-
ventures

45

Kanto Region


the number of bio
-
ventures



194

Kansai Region



the number of bio
-
ventures


7






Source:

The number of bio
-

venture companies in 2003


by Japan Bioindustry Association


The Bio Clusters in Japan






Biotechnology Industry in the

Kansai Region

Key Sectors:



Pharmaceuticals




䵥M楣慬i䥮獴牵浥湴n



䙵F捴楯湡氠䙯Fd


Pharmas in Kansai are concentrated in Osaka
‘Doshomachi’, the center of Osaka City.



30% of Japan’s pharmaceutical
-
related companies
and employees are concentrated in Kansai.



乵浢敲m⁰桡牭慳h楮i䭡湳n椬⁡牥

敱e楶慬敮琠瑯⁴桡琠
潦⁕⹋⸠潲.䙲慮F攮



Among the top 18 pharmas for sales in Japan, 8 have
their headquarters in Kansai.

Potential for the Pharmaceutical
Sector in Kansai

The Top 18 Pharmas in Japan


1. Takeda Pharmaceutical


2. Astellas
(Yamanouchi +
Fujisawa
)


3. Sankyo + Daiichi


4. Eisai


5. Shionogi


6. * Chugai Pharmaceutical


7. Taisho Pharmaceutical


8. * Banyu Pharmaceutical


9. Tanabe Seiyaku

10. Otsuka Pharmaceutical

11. Novartis Pharma

12. Kyowa Hakko Kogyo


13. Ono Pharmaceutical

14. Mitsubishi Pharma

15. Sumitomo Pharmaceuticals

16. GlaxoSmithKline

17. Dainippon Pharmaceutical

18. TAIHO Pharmaceutical


By Amount of sales for drugs:2003


AstraZeneca Japan


Eli Lilly Japan


卣桥物湧
-
偬潵P栠䬮䬮


Bayer Japan


Boehringer Ingelheim


卣桥物湧


佲条湯渠䩡灡p


乩桯渠䵥摩
-
偨祳楣i


Proctor & Gamble

Foreign Affiliated Bio
-
related
companies in Kansai

Concentration of Bio Research Institutions


Osaka University


(2,100 science researchers)


Osaka University Hospital and Faculty of Medicine


(advanced medical care:1,000beds)


National Cardiovascular Center


(100 researchers, 700beds)


Osaka City University Medical School


Osaka City University Medical School Hospital


Osaka Bioscience Institute



(40 researchers)


Biomolecular Engineering Research Institute


(60 researchers)


Fundamental Technology Research Center for



Studies on the Creation of New Medicines


(more than 50 researchers)

High
-
leveled Researches


1. Osaka University


2. Kyoto University


3. Okazaki National Research Institutes


4. Kobe University


5. Nagoya University


6. National Institute of Genetics


7. Tokyo University


8. Kyushu University


9. JICHI Medical School

10. Kyoto Prefectural University of Medicine


Distinguished Researchers in
Osaka


Immunology, Oncology


††
呡T慭楴獵s䭉午䥍O呏ⰠO獡歡s啮楶敲獩ey

††
呯獨楯 䡉剁乏ⰠO獡歡s啮楶敲獩ey


Shigekazu NAGATA, Osaka University



Biochemistry Neuroscience


††
卨楧整慤愠乁KA义午NⰠ䭹潴漠啮楶敲獩ey



Biochemistry


††
奡獵瑯浩m义午䥚啋NⰠO獡歡s啮楶敲獩ey

††
䵡獡M桩h奁NAG䥓AW䄬A呥硡猠啮楶敲獩ey ⡦潲浥爠䭹潴漠啮楶敲獩ey)



Immunology Molecular Cell


††
呥T獵s愠呁G䄬A䭵K慭a瑯 啮楶敲獩ey ⡦潲浥爠O獡歡s啮楶敲獩ey 偲潦敳獯爩



Pharmacology Physiology



Tomoh MASAKI, Tsukuba University (former Kyoto University)





Arterial sclerosis





Ischemic heart disease





High
-
blood pressure





Arthritis rheumatoides





Asthma





Atopic dermatitis





Obesity





Diabetes



Focused Diseases

Market for the Medical Instrument
Sector


Market Size in Japan


20 billion US$ (year 2002)






2
nd

largest market in the world.









80 billion US$

(year 2010)



Breakdown:



medical
-
treatment related equipments


44.7%


(PTCA catheter, pacemaker)



di慧nostic de癩ce





31.3%

† †††
⡥湤潳捯c攬⁃TⰠ䵒䤩



others†






24.0%



Source: Ministry of Health, Labor and Welfare


Changes in the Population Structure




Aging Society



Changes in the Disease Structure


Acute Disease
(infection)





Chronic Disease


(cancer, cardiac disorder,


cerebrovascular disease, diabetes)

Trends for Medical Care



Changes in the quality of medical care


examination & treatment prevention of disease




curing technology Quality of Life



Trends in Medical Care

Focused types of medical
instruments

Regeneration related

Cardiovascular related

Minimally invasive

treatment

Bio
-

Imaging

Automotive diagnostic system


Medical examination




偡牴湥牳桩r 睩瑨w潶o牳敡猠捯c灡湩敳


technical tie
-
ups


joint research and development



Internationalization

Application for patents for medical
instruments

0%
10%
20%
30%
40%
50%
60%
70%
Number of applications for patents: 11,537 (year 2000)

USA 64%

Europe 27%

Japan 9%

Nipro Corporation

SANYO Electric Biomedical

Toyobo Co., Ltd.

Teijin

Kaneka Corporation

Matsushita Electric Industrial Co., Ltd.

Shimadzu Corporation


OMRON Corporation


Kyocera Corporation

Companies in Kansai

Market for the

Functional Food Sector



Market Size in Japan


4.2 billion USD

(year 2003)




60 billion USD

(year 2010)




Source: Ministry of Economy, Trade and Industry



Potential Market for the

Functional Food Sector

0
1
2
3
4
5
6
7
8
9
10
High blood pressure
Cerebrovascular disease
I schemic heart disease
Diabetes
Chronic arthritis
Osteoporosis
Gastric and duodenal ulcer
Hepatitis
Asthma
Bronchitis
Cataract
Prostate-gland enlargement
Glomerular disease
Cancer
Alzheimer
Skin Aging
Companies in Kansai


Suntory Limited


Gekkeikan


Glico


Ikari Sauce


Kaneka




OCCI Activities for promotion

of Bio
-
industry


Study Group on Development of Functional Food



Japan Bio
-
technology Business Competition



BIO
-
Business School



FORUM for Industrialization of Next Generation Medical


Systems, Medical Treatment Systems



NANO
-
BIO Industrialization Seminars


ET
BIO Information Highway Plan
-
Phase II



ET
Bio
-
Delegation to USA (June 20
-
26, 2005)



Only Business Partnering event for foreign companies in Japan

September 12
th

and 13
th


The Simple Concept

+CONNECT+

Business Partnering Service


GVF Secretariat Pre
-
Arranges individual
business meetings before the event.


Search and contact the best suited
company
-
> division
-
> personnel

for the
presenting technology.


Nation
-
Wide promotion


12. 2 meetings

per


company
(8.0 pre
-
arranged)

Who’s in the Audience?

List of Participants from the past event


Asahi Chemical Industry Co.,Ltd.


Shimadzu Corporation


SUNTORY LTD.


Sekisui Chemical Co.,Ltd.


KANEKA Corporation


Sumitomo Chemical Co.,Ltd.


Hitachi Chemical Co.,Ltd.


Toyobo Co.,Ltd.


Kuraray Co.,Ltd.


Nippon Paint Co.,Ltd.


161

Companies,
345

People (2004)


Nippon Shokubai Co.,Ltd


Takeda Chemical
Industries,LTD.


SHIONOGI & Co.,LTD.


Fujisawa Pharmaceutical
Co.,Ltd.


Otsuka pharmaceutical
Co.,Ltd.

Result of Individual Meetings


7 companies concluded or about to conclude
Contracts.


( Technology tie ups, Joint Research, Joint


Development, Finance, etc)



10 companies continues their business
discussions.



0 company had no specific result

Quality First


Only Companies with excellent
technology are allowed to participate
after the evaluation by Nominating
Committee.



M
ain criteria :


Creativity of Technology and
Marketability of Products in Japan.


Software company from USA made a distribution
agreement with a major software distributor in Japan



䅧物扩漠捯浰c湹 晲潭o䩡J慮Ⱐ灲潤p捩湧c啂匠卯楬S
䅣瑩癡瑯爠v散e楶敤i楮癥獴浥湴⁦牯洠慮⁩湤畳瑲楡i
灲潭潴p潮o潲条o楺慴楯渠楮⁊慰a渮



A bio
-
tech company from Japan, developing innovative
technology to develop oral agents for drugs considered
difficult for oral absorption, received investment from an
investment firm.

Success Stories from GVF03

Process



Application Deadline


Screening Committee Meeting &


Notification to Presenters


Audience Recruiting


Payment Deadline for Participation Fee


Presenter’s Orientation



GVF05
-
BIO


June 20th

Mid
-
July

July 29th

May 20th

September 11th

September 12
th
-
13th

Participation Fee

-
Business Match
-
making Service

-
Individual Booth ( W3.0 x L1.5 x H1.5 in meters )

-
Simultaneous Interpretation for Presentation

-
A Professional Interpreter for business talks for 2days

-
Invitation to all GVF related events

-
Nation wide promotion


US$1,500
-

-
---
The Fee Covers
----


Incentives by the Osaka City Government

(tentative)


For companies planning to set up a business base in


Osaka City, there is a chance to receive refund of the


GVF05 Participation Fee from the IBPC Osaka Investment


Promotion Center.





1
-
Day Industrial Trip by METI
-
Kansai



(tentative)


The METI
-
Kansai is planning to hold another industrial trip


again for the GVF Participants after the GVF05
-
BIO event.

Incentives and a 1
-
Day Industrial
Trip in Kansai

How to Apply


Submit necessary documentations to appropriate
secretariat or coordinator via E
-
mail



Template file of Application form can be
downloaded from the WEB
http://www.gvf.ne.jp/



Attachment of Presentation helps

Thank you very much!!

Ryoichi Nakano

tel: +81
-
6
-
6944
-
6403

e
-
mail: gvf@osaka.cci.or.jp

http://www.gvf.or.jp/e

For further details and questions

Please contact